Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,692 | 538 | 98.7% |
| Education | $99.99 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,820 | 165 | $0 (2024) |
| Novo Nordisk Inc | $1,019 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $549.91 | 34 | $0 (2024) |
| PFIZER INC. | $440.75 | 28 | $0 (2024) |
| Lilly USA, LLC | $424.88 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $338.45 | 25 | $0 (2023) |
| Astellas Pharma US Inc | $316.62 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $294.32 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $275.43 | 19 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $248.78 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,113 | 131 | ABBVIE INC. ($591.88) |
| 2023 | $1,690 | 118 | ABBVIE INC. ($329.18) |
| 2022 | $1,885 | 141 | ABBVIE INC. ($471.92) |
| 2021 | $2,104 | 149 | AbbVie Inc. ($427.24) |
All Payment Transactions
539 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Genetic Disease | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: UROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Endocrinology | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Biological | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Oncology | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 258 | 431 | $74,258 | $24,334 |
| 2022 | 7 | 179 | 328 | $58,822 | $20,871 |
| 2021 | 5 | 168 | 271 | $49,292 | $17,849 |
| 2020 | 7 | 182 | 277 | $49,939 | $15,525 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 231 | $56,133 | $16,911 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $10,664 | $4,363 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,752 | $882.67 | 32.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,617 | $791.23 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $1,044 | $514.80 | 49.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 46 | $1,426 | $437.92 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 47 | $470.00 | $394.80 | 84.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 19 | $152.00 | $39.60 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 217 | $47,032 | $15,886 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $6,435 | $2,844 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $1,484 | $747.38 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $2,096 | $699.60 | 33.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $748.00 | $378.26 | 50.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 17 | 29 | $899.00 | $278.23 | 30.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 17 | $128.00 | $37.51 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 186 | $37,572 | $13,190 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 35 | 35 | $7,665 | $3,710 | 48.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,410 | $700.08 | 20.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $456.00 | $187.44 | 41.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 27 | $189.00 | $60.75 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 173 | $34,946 | $10,098 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 18 | 18 | $3,942 | $1,665 | 42.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 14 | 22 | $3,388 | $1,498 | 44.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,270 | $1,138 | 21.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 14 | 14 | $1,708 | $854.00 | 50.0% |
About Bridget Shepherd Depaul, APRN
Bridget Shepherd Depaul, APRN is a Nurse Practitioner healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1750751517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bridget Shepherd Depaul, APRN has received a total of $7,792 in payments from pharmaceutical and medical device companies, with $2,113 received in 2024. These payments were reported across 539 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,692).
As a Medicare-enrolled provider, Shepherd Depaul has provided services to 787 Medicare beneficiaries, totaling 1,307 services with total Medicare billing of $78,579. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Lexington, KY
- Active Since 10/05/2015
- Last Updated 12/02/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1750751517
Products in Payments
- VRAYLAR (Drug) $801.07
- TRELEGY ELLIPTA (Drug) $481.47
- NURTEC ODT (Drug) $434.91
- QULIPTA (Drug) $417.61
- UBRELVY (Drug) $405.88
- JARDIANCE (Drug) $352.35
- TRINTELLIX (Drug) $338.45
- REXULTI (Drug) $323.15
- Ozempic (Drug) $266.82
- Wegovy (Drug) $219.43
- Rybelsus (Drug) $192.34
- Kerendia (Drug) $188.55
- MYRBETRIQ (Drug) $162.47
- ELIQUIS (Drug) $157.89
- AIRSUPRA (Drug) $154.32
- Saxenda (Drug) $103.20
- Aimovig (Biological) $103.00
- SOLIQUA 100/33 (Biological) $102.71
- XIFAXAN (Drug) $100.45
- FREESTYLE LIBRE 3 (Device) $96.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lexington
Rachael Bradford, Aprn, APRN
Nurse Practitioner — Payments: $369,931
Jessica Schorck, Aprn, APRN
Nurse Practitioner — Payments: $19,669
Juawanna Schuller, Arnp, ARNP
Nurse Practitioner — Payments: $19,426
Mrs. Megan Collett, Aprn, APRN
Nurse Practitioner — Payments: $10,839
Holly Chitwood, Aprn, APRN
Nurse Practitioner — Payments: $8,212
Robin Sutcliffe, Aprn, APRN
Nurse Practitioner — Payments: $8,003